Menu

CME Corner

Active Programs

Identifying and Diagnosing Interstitial Lung Disease

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are commonly mischaracterized, and a correct diagnosis is often delayed. This activity will examine strategies for identifying and accurately diagnosing ILD. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Idiopathic Pulmonary Fibrosis: Developing Evidence-Based Management Plans

Treatment of ILD can be a challenge for clinicians; poor outcomes and health-related quality of life attest to the significant care gaps and treatment limitations that remain. Advances in the treatment of ILD, and particularly in idiopathic pulmonary fibrosis (IPF), hold promise for improved care and patient outcomes. This activity will examine management strategies for IPF. ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Evolving Standards of Care in Metastatic Prostate Cancer

For patients with metastatic prostate cancer (mPRCA), the number of metastases has prognostic and therapeutic implications. Clinicians who treat patients with mPRCA need to recognize patients with oligometastatic prostate cancer and be aware that management of patients with fewer than 5 metastases is different from that of patients with polymetastatic disease. Recommendations for the initial manag ...

  • Online Presentation Online Presentation
  • ACCME

The Changing Landscape of Interstitial Lung Disease

Many patients with interstitial lung disease (ILD) do not receive a timely and accurate diagnosis prior to considerable disease progression. Management guidelines are vague and treatment options have been limited, leading to negative health outcomes and decreased quality of life. Advances in diagnostic strategies, recently approved therapies, and new clinical trial data, however, are changing best ...

  • Online Presentation
  • ACCME

Expired Programs

Dialogue with the Experts: Strategies for Improving Interstitial Lung Disease Diagnosis and Treatment

An early and accurate diagnosis of ILD and its specific type is vital to directing therapy and monitoring disease course and therapeutic response, but these conditions are often mischaracterized and a correct diagnosis is very often delayed. This activity will examine recent advances in ILD diagnosis and treatment. ...

  • Video Roundtable Video Roundtable
  • ACCME

Patient-Centered Care in Advanced Prostate Cancer

Recommended treatment options for prostate cancer vary based on disease severity and life expectancy, with traditional approaches including active surveillance, surgery, radiation therapy, chemotherapy, and androgen deprivation therapy (ADT). Prostate cancer that progresses despite ADT is known as castration-resistant prostate cancer (CRPC). Until recently, the standard of care for CRPC patients w ...

  • Mobile + Online on Univadis Mobile + Online on Univadis
  • ACCME

Updates on Molecular Testing in NSCLC

Oncologists have new options when treating advanced NSCLC. The use of molecular profiling to define subgroups of patients most likely to experience clinical benefit from novel targeted therapies has been endorsed by both ASCO and the National Comprehensive Cancer Network (NCCN).This activity will examine the role of molecular biomarkers in patients with advanced NSCLC. ...

  • Mobile + Online on Univadis
  • ACCME
Main Menu
EDITOR'S PICKS